Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach (vol 11, 591854, 2020)-MedSci.cn - williamhill asia

Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach (vol 11, 591854, 2020)

Liu, SB; Wang, ZT; Tian, X; Cai, WM

Tian, X (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Pharm, Zhengzhou, Peoples R China.; Cai, WM (corresponding author), Fudan Univ, Sch Pharm, Dept ClinicalPharm, Shanghai, Peoples R China.

FRONTIERS IN PHARMACOLOGY, 2021; 12 ():

科室
- - 订阅+
  - 更多科室
工具
服务